Citalopram Intervention for Hostility: Results of a Randomized Clinical Trial

Journal of Consulting and Clinical Psychology

Volumn 77, Issue 1, 2009, Pages 174-188

  Kamarck, Thomas W ^a   Haskett, Roger F ^a   Muldoon, Matthew ^a   Flory, Janine D ^b   Anderson, Barbara ^a   Bies, Robert ^c   Pollock, Bruce ^a   Manuck, Stephen B ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

cardiovascular disease; hostility; social support; SSRIs; treatment

Indexed keywords

CITALOPRAM; PLACEBO;

ADULT; AGGRESSIVENESS; ANGER; ARTICLE; CARDIOVASCULAR RISK; CENTRAL NERVOUS SYSTEM; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG WITHDRAWAL; DRY THROAT; ELECTRONIC MEDICAL RECORD; FEMALE; HOSTILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVOUSNESS; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SOCIAL SUPPORT; VERBAL HOSTILITY; XEROSTOMIA;

ADULT; AGGRESSION; CARDIOVASCULAR DISEASES; CITALOPRAM; DRUG ADMINISTRATION SCHEDULE; FEMALE; HOSTILITY; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; QUESTIONNAIRES; SEROTONIN UPTAKE INHIBITORS; SOCIAL SUPPORT; VERBAL BEHAVIOR;

EID: 60849129119     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/a0014394     Document Type: Article

References (78)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed., Text Revision (2000), Author, Washington, DC
2. van het Rot M., Moskowitz D.S., Pinard G., and Young S.N. Social behaviour and mood in everyday life: The effects of tryptophan in quarrelsome individuals. Journal of Psychiatry and Neuroscience 31 (2006) 253-262
3. Barefoot J.C., Dodge K.A., Peterson B.L., Dahlstrom W.G., and Williams R.B. The Cook-Medley Hostility Scale: Item content and ability to predict survival. Psychosomatic Medicine 51 (1989) 46-57
4. Barefoot J.C., and Lipkus I.M. The assessment of anger and hostility. In: Smith T.W. (Ed). Anger, hostility, and the heart (1994), Erlbaum, Hillsdale, NJ 43-66
5. Barratt E.S. Impulsiveness subtraits: Arousal and information processing. In: Spence J.T., and Izard C.E. (Eds). Motivation, emotion, and personality (1985), Elsevier Science, Amsterdam 137-146
6. Beck A.T., Steer R.A., and Brown G.K. Manual for the Beck Depression Inventory. 2nd ed. (1996), Psychological Corporation, San Antonio, TX
7. Berkman L.F., Leo-Summers L., and Horwitz R.I. Emotional support and survival after myocardial infarction: A prospective, population-based study of the elderly. Annals of Internal Medicine 117 (1992) 1003-1009
8. Bies R.R., Feng Y., Lotrich F.E., Kirshner M.A., Roose S., Kupfer D.J., et al. Utility of sparse concentration sampling for citalopram in elderly clinical trial subjects. Journal of Clinical Pharmacology 44 (2004) 1352-1359
9. Bleil M.E., McCaffery J.M., Muldoon M.F., Sutton-Tyrrell K., and Manuck S.B. Anger-related personality traits and carotid artery atherosclerosis in untreated hypertensive men. Psychosomatic Medicine 66 (2004) 633-639
10. Botchin M.B., Kaplan J.R., Manuck S.B., and Mann J.J. Low versus high prolactin responders to fenfluramine challenge: Marker of behavioral differences in adult male cynomolgus macaques. Neuropsychopharmacology 9 (1993) 93-99
11. Burke L.E. Electronic measurement. In: Burke L.E., and Ockene I.S. (Eds). Compliance in healthcare and research (2001), Futura, Armonk, NY 117-138
12. Bushman B.J., Cooper H.M., and Lemke K.M. Meta-analysis of factor analyses: An illustration using the Buss-Durkee Hostility Inventory. Personality and Social Psychology Bulletin 17 (1991) 344-349
13. Buss A.H., and Durkee A. An inventory for assessing different kinds of hostility. Journal of Consulting Psychology 21 (1957) 343-349
14. Buss A.H., and Perry M. The Aggression Questionnaire. Journal of Personality and Social Psychology 63 (1992) 452-459
15. Cherek D.R., Lane S.C., Pietras C.J., and Steinberg J.L. Effects of chronic paroxetine administration on measures of aggressive and impulsive responses of adult males with a history of conduct disorder. Psychopharmacology 159 (2002) 266-274
16. Cleare A.J., and Bond A.J. Does central serotonergic function correlate inversely with aggression? A study using d-fenfluramine in healthy subjects. Psychiatry Research 69 (1997) 89-95
17. Coccaro E.F. Central serotonin activity and aggression: Inverse relationship with prolactin response to d-Fenfluramine, but not CSF 5-HIAA concentration, in human subjects. American Journal of Psychiatry 154 (1997) 1430-1435
18. Coccaro E.F., and Kavoussi R.J. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Archives of General Psychiatry 54 (1997) 1081-1088
19. Coccaro E.F., Siver L.J., Kalar H.M., Maurer G., Cochrane K., Cooper T.B., et al. Serotonergic studies in patients with affective and personality disorders. Archives of General Psychiatry 46 (1989) 587-599
20. Cohen S., Mermelstein R., Kamarck T.W., and Hoberman H.M. Measuring the functional components of social support. In: Sarason I.G., and Sarason B.R. (Eds). Social support: Theory, research and applications (1985), Martinus Nijhoff, Boston 73-94
21. Cook W.W., and Medley D.M. Proposed hostility and pharisaic-virtue scales for the MMPI. Journal of Applied Psychology 38 (1954) 414-418
22. Dembroski T.M., MacDougall J.M., Costa Jr. P.T., and Grandits G.A. Components of hostility as predictors of sudden death and myocardial infarction in the multiple risk factor intervention trial. Psychosomatic Medicine 51 (1989) 514-522
23. Depue R.A., and Spoont M.R. Conceptualizing a serotonin trait: A behavioral dimension of constraint. Annals of the New York Academy of Sciences 487 (1986) 47-62
24. Everson-Rose S.A., and Lewis T.T. Psychosocial factors and cardiovascular diseases. Annual Review of Public Health 26 (2005) 469-500
25. Fava M., Rosenbaum J.R., Pava J.A., McCarthy M.K., Steingard R.J., and Bouffides E. Anger attacks in unipolar depression, Part 1: Clinical correlates and response to fluoxetine treatment. American Journal of Psychiatry 150 (1993) 1158-1163
26. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-Patient Edition (SCID-I/NP) (2002), Biometrics Research, New York State Psychiatric Institute, New York
27. Flory J.D., Mann J.J., Manuck S.B., and Muldoon M.F. Recovery from major depression is not associated with normalization of serotonergic function. Biological Psychiatry 43 (1998) 320-326
28. Friedman R.A., and Leon A.C. Expanding the black box-Depression, antidepressants, and the risk of suicide. New England Journal of Medicine 356 (2007) 2343-2346
29. Gellman A., Carlin J.B., Stern H.S., and Rubin D.B. Bayesian data analysis (1995), Chapman & Hall, Boca Raton, FL
30. Gidron Y., Davidson K., and Bata I. The short-term effects of a hostility-reduction intervention on male coronary heart disease patients. Health Psychology 18 (1999) 416-420
31. Glassman A.H., O'Connor C.M., Califf R.M., Swedberg K., Schwartz P., Bigger J.T., et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. Journal of the American Medical Association 288 (2002) 701-709
32. Grano N., Virtanen M., Vahtera J., Elovainio M., and Kivimaki M. Impulsivity as a predictor of smoking and alcohol consumption. Personality and Individual Differences 37 (2004) 1693-1700
33. Harris J.A. Confirmatory factor analysis of the Aggression Questionnaire. Behaviour Research and Therapy 33 (1995) 991-993
34. Higley J.D., King S.T., Hasert M.F., Champoux M., Suomi S.J., and Linnoila D.M. Stability of interindividual differences in serotonin function and its relationship to severe aggression and competent social behavior in rhesus macaque females. Neuropsychopharmacology 14 (1996) 67-76
35. Higley J.D., Mehlman P.T., Higley S.B., Fernald B., Vickers J., Lindell S.G., et al. Excessive mortality in young free-ranging male nonhuman primates with low cerebrospinal fluid 5-hydroxyindoleacetic acid concentrations. Archives of General Psychiatry 53 (1996) 436-441
36. Knutson B., Wolkowitz O.M., Cole S.W., Chan T., Moore E.A., Johnson R.C., et al. Selective alteration of personality and social behavior by serotonergic intervention. American Journal of Psychiatry 155 (1998) 373-379
37. Kruesi M.J., Rapoport J.L., Hamburger S., Hibbs E., Potter W.Z., Lenane M., et al. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Archives of General Psychiatry 47 (1990) 419-426
38. Malone K.M., Waternaux C., Haas G.L., Cooper T.B., Li S., and Mann J.J. Cigarette smoking, suicidal behavior, and serotonin function in major psychiatric disorders. American Journal of Psychiatry 160 (2003) 773-779
39. Mann J.J., McBride A., Malone K.M., DeMeo M., and Kelip J. Blunted serotonergic responsivity in depressed inpatients. Neuropsychopharmacology 13 (1995) 53-64
40. Manuck S.B., Flory J.D., Ferrell R.E., Mann J.J., and Muldoon M.F. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Research 95 (2000) 9-23
41. Manuck S.B., Flory J.D., McCaffery J.M., Matthews K.A., Mann J.J., and Muldoon M.F. Aggression, impulsivity and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19 (1998) 287-299
42. Martin R., Watson D., and Wan C.K. A three-factor model of trait anger: Dimensions of affect, behavior, and cognition. Journal of Personality 68 (2000) 869-897
43. Mehlman P.T., Higley J.D., Faucher I., Lilly A.A., Taub D.M., Vickers J., et al. Correlation of CSF 5-HIAA concentration with sociality and the timing of emigration in free-ranging primates. American Journal of Psychiatry 152 (1995) 907-913
44. Menys V.C., Smith C., Lewins P., Farmer R., and Noble M. Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine. Clinical Science 91 (1996) 87-92
45. Miller T.Q., Smith T.W., Turner C.W., Guijarro M.L., and Hallet A.J. A meta-analytic review of research on hostility and physical health. Psychological Bulletin 119 (1996) 322-348
46. Morse J.Q., and Pilkonis P.A. Screening for personality disorders. Journal of Personality Disorders 21 (2007) 179-198
47. Moskowitz D.S., Pinard G., Zuroff D.C., Annable L., and Young S.N. The effect of tryptophan on social interaction in everyday life: A placebo-controlled study. Neuropsychopharmacology 25 (2001) 277-289
48. Muldoon M.F., Barger S.D., Ryan C.M., Flory J.D., Lehoczky J.P., Matthews K.A., et al. Effects of lovastatin on cognitive function and psychological well-being. American Journal of Medicine 108 (2000) 538-547
49. Muldoon M.F., Mackey R.H., Korytkowski M.T., Flory J.D., Pollock B.G., and Manuck S.B. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. Journal of Clinical Endocrinology and Metabolism 91 (2006) 718-721
50. Muldoon M.F., Mackey R.H., Williams K.V., Korytkowski M.T., Flory J.D., and Manuck S.B. Low central nervous system serotonergic responsivity is associated with the metabolic syndrome and physical inactivity. Journal of Clinical Endocrinology and Metabolism 89 (2004) 266-271
51. Musselman D.L., Evans D.L., and Nemeroff C.B. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Archives of General Psychiatry 55 (1998) 580-592
52. Nemeroff C.B., and Schatzberg A.F. Pharmacological treatments for unipolar depression. In: Nathan P.E., and Gorman J.M. (Eds). A guide to treatments that work. 3rd ed. (2007), Oxford University Press, New York 271-307
53. Pilkonis P., Yookyung K., Proietti J.M., and Barkham M. Scales for personality disorders developed from the Inventory of Interpersonal Problems. Journal of Personality Disorders 10 (1996) 355-369
54. Pollock B.G., Laghrissi-Thode F., and Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. Journal of Clinical Psychopharmacology 20 (2000) 137-140
55. Pollock B.G., Mulsant B.H., Sweet R.A., Burgio L.D., Kirshner M.A., and Shuster K. An open pilot study of citalopram for behavioral disturbances of dementia: Plasma levels and real-time observations. American Journal of Geriatric Psychiatry 5 (1997) 70-78
56. Radloff L.S. The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1 (1977) 385-401
57. Raleigh M.J., McGuire M.T., Brammer G.L., Pollack D.B., and Yuwiler A. Serotonergic mechanisms promote dominance acquisition in adult male vervet monkeys. Brain Research 559 (1991) 181-190
58. Ramirez J.M., and Andreu J.M. Aggression, and some related psychological constructs (anger, hostility, and impulsivity) Some comments from a research project. Neuroscience and Biobehavioral Reviews 30 (2006) 276-291
59. Rasmussen A., Lunde M., Poulsen D.L., Sorensen K., Qvitzau S., and Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics 44 (2003) 216-221
60. Raynor D.A., Pogue-Geile M.F., Kamarck T.W., McCaffery J.M., and Manuck S.B. Covariation of psychosocial characteristics associated with cardiovascular disease: Genetic and environmental influences. Psychosomatic Medicine 64 (2002) 191-203
61. Rosenman R.H. The interview method of assessment of the coronary-prone behavior pattern. In: Dembroski T.M., Shields J.L., Haynes S.G., and Feinlieb M. (Eds). Coronary-prone behavior (1978), Springer-Verlag, New York
62. Salzman C., Wolfson A.N., Schatzberg A., Looper J., Henke R., Albanese M., et al. Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. Journal of Clinical Psychopharmacology 15 (1995) 23-29
63. Scales A.C., and Doraiswamy P.M. Focus on citalopram: A selective serotonin reuptake inhibitor for the treatment of depression. Formulary 33 (1998) 725-743
64. Siegman A.W., Dembroski T.M., and Ringel N. Components of hostility and the severity of coronary artery disease. Psychosomatic Medicine 49 (1987) 127-135
65. Siever L., and Trestman R.L. The serotonin system and aggressive personality disorder. International Clinical Psychopharmacology 8 (1993) 33-39
66. Smith T.W. Current status of a psychosomatic hypothesis. Health Psychology 11 (1992) 139-150
67. Smith T.W., and Frohm K.D. What's so unhealthy about hostility? Construct validity and psychosocial correlates of the Cook and Medley Ho scale. Health Psychology 4 (1985) 503-520
68. Spielberger C.D. Manual for the State-Trait Anger Expression Inventory (STAXI) (1988), Psychological Assessment Resources, Odessa, FL
69. Spoont M.R. Modulatory role of serotonin in neural information processing: Implications for human psychopathology. Psychological Bulletin 112 (1992) 330-350
70. Suls J., and Bunde J. Anger, anxiety, and depression as risk factors for cardiovascular disease: The problems and implications of overlapping affective dispositions. Psychological Bulletin 131 (2005) 260-300
71. Taylor C.B., Youngblood M.E., Catellier D., Veith R.C., Carney R.M., Burg M.M., et al. Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Archives of General Psychiatry 62 (2005) 792-798
72. Tse W.S., and Bond A.J. Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology 161 (2002) 324-330
73. Vrijens B., Tousset E., Rode R., Bertz R., Mayer S., Urquhart J., et al. Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models. Journal of Clinical Pharmacology 45 (2005) 461-467
74. Welin C., Lappas G., and Wilhelmsen L. Independent importance of psychosocial factors for prognosis after myocardial infarction. Journal of Internal Medicine 247 (2000) 629-639
75. Williams J.E., Nieto F.J., Sanford C.P., Couper D.J., and Tyroler H.A. The association between trait anger and incident stroke risk: The atherosclerosis risk in communities (ARIC) study. Stroke 33 (2002) 19-20
76. Williams J.E., Paton C.C., Siegler I.C., Eigenbrodt M.L., Nieto F.J., and Tyroler H.A. Anger proneness predicts coronary heart disease risk: Prospective analysis from the atherosclerosis risk in communities (ARIC) study. Circulation 101 (2000) 2034-2039
77. Williams R.B. Basic biological mechanisms. In: Siegman A.W., and Smith T.W. (Eds). Anger, hostility, and the heart (1994), Hove, Hillsdale, NJ 117-126
78. Williams R.B. Neurobiology, cellular and molecular biology, and psychosomatic medicine. Psychosomatic Medicine 56 (1994) 308-315